PRTN3 and rheumatoid arthritis: Notwithstanding the association of CXCL13 with CRP levels as well as the ACPA-status, both regarded as indicators of less favourable outcomes in RA [32,33], PD activity at 12 months in our cohort was uniquely explained by different levels of the chemokine.